0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover670.12%IV-3594.58%PremiumJan 17, 2025Expiry Date7.30Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9146Delta0.7843Gamma0.03Leverage Ratio-0.0008Theta-0.0011Rho-0.02Eff Leverage0.0001Vega
Syros Pharmaceuticals Stock Discussion
👀
I'm wondering if Oxford Finance will demand immediate payment on the loan or if they will give some support by negotiating the loan? I don't know much. How likely are the odds on these 2?
Will the share price go to zero?
Syros Announces Topline Data From Select-Mds-1 Phase 3 Trial of Tamibarotene in Higher-Risk Myelodysplastic Syndrome With Rara Gene Overexpression! Did not meet endpoint!
No comment yet